Smith & Nephew (SNN) Earning Somewhat Favorable Press Coverage, Report Finds

News articles about Smith & Nephew (NYSE:SNN) have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Smith & Nephew earned a coverage optimism score of 1.13 on their scale. InfoTrie also assigned media headlines about the medical equipment provider an news buzz score of 2 out of 10, meaning that recent news coverage is very unlikely to have an impact on the stock’s share price in the near term.

SNN stock opened at $36.21 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market cap of $15.86 billion, a price-to-earnings ratio of 19.06, a PEG ratio of 2.97 and a beta of 0.58. Smith & Nephew has a fifty-two week low of $32.22 and a fifty-two week high of $39.85.

Several equities research analysts have issued reports on SNN shares. Zacks Investment Research raised Smith & Nephew from a “hold” rating to a “buy” rating and set a $40.00 price target for the company in a report on Wednesday, August 29th. Canaccord Genuity reaffirmed a “buy” rating and set a $42.00 price target on shares of Smith & Nephew in a report on Monday, August 6th. HSBC downgraded Smith & Nephew from a “buy” rating to a “hold” rating in a report on Tuesday, October 16th. Finally, UBS Group downgraded Smith & Nephew from a “buy” rating to a “neutral” rating in a report on Wednesday, August 8th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. Smith & Nephew has an average rating of “Hold” and a consensus price target of $41.00.

ILLEGAL ACTIVITY NOTICE: “Smith & Nephew (SNN) Earning Somewhat Favorable Press Coverage, Report Finds” was first published by WKRB News and is the sole property of of WKRB News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at

About Smith & Nephew

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Featured Article: Return on Investment (ROI)

Insider Buying and Selling by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with's FREE daily email newsletter.

Leave a Reply